Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine, Idarubicin, and Cytarabine for Younger AML Patients
NCT01025154Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2010
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2010; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01025154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025154.